Status:
WITHDRAWN
Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Pain
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine how the drug ketorolac, when given with the spinal morphine, affects pain.
Detailed Description
This study is part of a pain center grant that focuses on how pain, especially chronic neuropathic pain, alters the response to traditional and non-traditional analgesics (pain medications). To treat...
Eligibility Criteria
Inclusion
- Implanted spinal pump for at last 9 months
- Must be receiving and the dose must have been doubled in the past 6 months
- Currently taking 60-200 mg morphine equivalent as oral rescue per day
- Men and women, ages 18-70
- Weigh no more that 250 pounds
- Neuropathic pain
Exclusion
- Pregnancy
- Unstable medical problems (heart lung, liver, kidney, or nervous system)
- Allergy to morphine, ketorolac, or drugs which may be used to treat side effects
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00349401
Start Date
December 1 2006
Last Update
November 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.